Table 2.

Demographics, diagnosis, and treatment characteristics by sex.

Characteristic	Total (n = 26)	Males (n = 18)	Females (n = 8)
Age (y) M(SD)	27.7 (5.1)	24.0 (3.9)	25.7 (5.4)
Duration since onset
0–6 months	10 (38.5%)	6 (33.3%)	4 (50.0%)
>6 months	16 (61.5%)	12 (66.7%)	4 (50.0%)
Ethnicity (%)
White British	22 (84.6%)	16 (88.9%)	6 (75.0%)
Asian	2 (7.6%)	2 (11.2%)	0
Chinese	1 (3.8%)	0	1 (12.5%)
Undeclared	1 (3.8%)	0	1 (12.5%)
Primary SCID diagnosis
FEP	11 (42.3%)	7 (38.9%)	4 (50.0%)
Schizophrenia	11 (42.3%)	9 (50.0%)	2 (25.0%)
Bipolar	2 (7.7%)	1 (5.6%)	1 (12.5%)
ARMS	1 (3.8%)	0	1 (12.5%
Non-organic	1 (3.8%)	1 (5.6%)	0
Antipsychotic Treatment (%)
No medication	1 (3.8%)	1 (5.6%)	0
Aripiprazole	3 (11.5%)	1 (5.6%)	2 (25.0%)
Clozapine	10 (38.5%)	10 (55.6%)	0
Olanzapine	5 (19.2%)	2 (11.1%)	3 (37.5%)
Quetiapine	5 (19.2%)	2 (11.1%)	3 (37.5%)
Risperidone	2 (7.7%)	2 (11.1%)	0
Antidepressant Treatment (%)
Citalopram	3 (11.5%)	2 (11.1%)	1 (12.5%)
Sertraline	2 (7.7%)	1 (5.6%)	1 (12.5%)
Venlafaxine	2 (7.7%)	0	2 (25.0%)
Fluoxetine	3 (11.5%)	1 (5.6%)	2 (25.0%)